Ready to dispense, right off the shelf¹

Norliqva is a ready-to-use oral solution
with no compounding, shaking, or refrigeration required¹

An option to consider if your patient has trouble with or prefers not to swallow pills.^1-3

• Ready to stock¹

• Stable for 24 months at room temperature^1,4

• Temperature excursions permitted from 15°C to 30°C (59°F to 86°F)¹

• No crushing or sprinkling¹

• Alcohol-free and berry flavor¹

• Lower wholesale acquisition costs^*

^*Representations herein are based on wholesale acquisition cost (WAC) as published in Medi-Span as of 10/16/26: Norliqva^® 150-mL bottle $515; Katerzia^® 150-mL bottle $658.97. WAC is the manufacturer’s published list price to wholesalers and does not include discounts, rebates, or other price concessions. WAC does not represent the price paid by pharmacies, payers, or patients. Actual patient cost depends on insurance coverage, formulary status, pharmacy, and other factors. Pricing is subject to change.

^†This piece represents coverage as of 10/20/26. Please reach out to the specific insurance carrier in question to determine coverage at the point at which you would like to access coverage. Speak directly to the applicable insurance provider to understand any individual’s specific coverage. Covered products can include considerations such as cost-sharing, prior authorization, or step therapy requirements.

^‡Norliqva is covered by state Medicaid fee-for-service programs in all 50 states and the District of Columbia as of 10/20/26, according to MCO HUB. Coverage is not a guarantee of payment. Requirements vary by state and by Medicaid managed care plan and may include prior authorization, step therapy, quantity limits, or preferred drug list restrictions. Coverage is subject to change without notice. Contact the state Medicaid program or managed care plan to verify coverage for an individual patient. The EasyPay Copay Program is not valid for patients enrolled in Medicaid, or any other state or federally funded healthcare program.